1. Home
  2. TRNS vs CAPR Comparison

TRNS vs CAPR Comparison

Compare TRNS & CAPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Transcat Inc.

TRNS

Transcat Inc.

HOLD

Current Price

$56.17

Market Cap

661.7M

Sector

Industrials

ML Signal

HOLD

Logo Capricor Therapeutics Inc.

CAPR

Capricor Therapeutics Inc.

HOLD

Current Price

$26.07

Market Cap

324.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TRNS
CAPR
Founded
1964
2005
Country
United States
United States
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
661.7M
324.6M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TRNS
CAPR
Price
$56.17
$26.07
Analyst Decision
Buy
Strong Buy
Analyst Count
4
8
Target Price
$108.67
$37.75
AVG Volume (30 Days)
135.6K
5.8M
Earning Date
01-26-2026
11-10-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
1.22
N/A
Revenue
$302,584,000.00
$11,130,509.00
Revenue This Year
$20.17
N/A
Revenue Next Year
$7.66
$7,736.03
P/E Ratio
$46.90
N/A
Revenue Growth
11.81
N/A
52 Week Low
$50.23
$4.30
52 Week High
$111.45
$40.37

Technical Indicators

Market Signals
Indicator
TRNS
CAPR
Relative Strength Index (RSI) 47.63 71.27
Support Level $50.23 $4.30
Resistance Level $56.90 $29.23
Average True Range (ATR) 2.94 3.27
MACD 0.87 1.66
Stochastic Oscillator 65.21 60.24

Price Performance

Historical Comparison
TRNS
CAPR

About TRNS Transcat Inc.

Transcat Inc is involved in providing calibration and laboratory instrument services and the distribution of test, measurement, and control instrumentation. The product and services portfolio of the company consists of calibration instruments, dimensional measuring tools, Electrical test instruments, pressure measurement, and others. The firm has Service and Distribution operating segments. The company derives the majority of its revenues from the Service segment. The firm promotes and sells its products under brand names such as Extech, FLIR, Fluke, Keysight, Megger, and others.

About CAPR Capricor Therapeutics Inc.

Capricor Therapeutics Inc is a clinical-stage biotechnology company focused on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (DMD), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with high unmet medical needs. The company's product pipeline includes CAP-1002, deramiocel an allogeneic cardiac-derived cell therapy. Deramiocel is currently advancing through Phase 3 clinical development for the treatment of Duchenne muscular dystrophy. Through its proprietary StealthXTM platform, the group uses its exosome technology to conduct preclinical research focused on vaccinology, delivering oligonucleotides, proteins, and small molecules to treat.

Share on Social Networks: